6640--Ortho Blood Bank Reagents

1.0 DISCLAIMER This Request for Information (RFI) is issued in accordance with FAR 10.001 to determine the availability and technical capabilities of qualified sources. Please respond to the questions in section 3.0. The associated North American Industrial Classification System (NAICS) code for this procurement is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. The FAR Provision found at 52.204-7(b)(1) requires that all offerors obtain a UEI to register in SAM. You may access the SAM website at https://www.sam.gov. This notice is for planning purposes only and does not constitute a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. This RFI is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for, or award, a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes. 2.0 DESCRIPTION OF ANTICIPATED NEED The Upstate New York VA Medical Centers of Albany, Buffalo, and Syracuse Pathology and Laboratory Medicine Service (PLMS) have a requirement for Blood Bank screening and anti-body ID products for use with VA Medical Center owned Ortho Clinical Diagnostics ID-MTS Workstations. All products provided shall be FDA approved for use with the ID-MTS Workstations. Additionally, the products must be FDA approved for immediate use with Ortho IgG gel cards and Ortho workstations, without secondary validation before use. The VA is conducting market research to identify potential sources that possess the capabilities to meet the requirement. The Government intends to award a firm, fixed-priced contract for a base year plus four (4) option years. The product numbers referenced below are those of QuidelOrtho Clinical Diagnostics and are meant to be descriptive but not restrictive. Refer to the table below for the list of reagents and/or consumables required: Item Number Description Estimated Annual Usage MTS084024 MTS Anti-IgG Card (Rabbit) 26 6902315 0.8% SELECTOGEN 78 6902317 0.8% PANEL A 39 DELIVERY REQUIREMENTS All items must be delivered to: Albany: Stratton VA Medical Center 113 Holland Avenue, Albany, NY 12208 Buffalo: VA Western NY Healthcare System 3495 Bailey Avenue, Buffalo, NY 14215 Syracuse: Syracuse VA Medical Center 800 Irving Avenue, Syracuse, NY 13210 3.0 QUESTIONS Business Size: Type of Business of Prime Contractor (Check all applicable boxes) Large Business Small Business (Check type of Small Business Below, if applicable) Small Disadvantaged Business (SBA Certified) Women-Owned Small Business HUB Zone Small Business (SBA Certified) Veteran Owned Small Business* Serviced Disabled Veteran Owned Small Business* 8(a) Small Business (SBA Certified) *If SDVOSB or VOSB indicate if your company is certified on VetCert Does your company maintain any Schedule Contracts (e.g., GSA, GWAC, FSS etc.)? If so, are any of the required supplies on your contract? (please provide the contract number, expiration date, and Government point of contact). Does your company have the ability to provide the medical supplies listed under the 2.0 DESCRIPTION OF ANTICIPATED NEED section above? Do you have any questions about the requirement? Are you a manufacturer or authorized distributor of this equipment? Please provide a capability statement that includes your SAM.gov UEI number. Responses are due via email to latriece.bruce@va.gov by 12:00 PM Eastern Standard Time (EST) June 29, 2026. DISCLAIMER: This Source Sought/RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this Source/Sought RFI. The Government is not obligated to provide comments to vendor submissions.